EICHOR
● Active Not Recruiting
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies
Condition: Non-Hodgkin Lymphoma · Sponsor: Genentech, Inc.
About this study
This study will evaluate the efficacy, safety, and pharmacokinetics of mosunetuzumab subcutaneous (SC) formulation in participants with selected B-cell malignancies (types of non-Hodgkin's lymphoma \[NHL\]).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (39)
| Infirmary Cancer Care | Mobile, Alabama, United States | — |
| Alaska Oncology & Hematology, LLC | Anchorage, Alaska, United States | — |
| Mayo Clinic Arizona | Phoenix, Arizona, United States | — |
| City of Hope | Duarte, California, United States | — |
| Rocky Mountain Cancer Centers (Aurora) - USOR | Aurora, Colorado, United States | — |
| Medical Oncology Hematology Consultants | Newark, Delaware, United States | — |
| SCRI Florida Cancer Specialists South | Fort Myers, Florida, United States | — |
| Mayo Clinic Jacksonville - PPDS | Jacksonville, Florida, United States | — |
| Cancer Specialists of North Florida - Jacksonville | Jacksonville, Florida, United States | — |
| Florida Cancer Specialists - NORTH - SCRI - PPDS | St. Petersburg, Florida, United States | — |
| Florida Cancer Specialists - EAST - SCRI - PPDS | West Palm Beach, Florida, United States | — |
| Mission Blood and Cancer - MercyOne Cancer Center | Des Moines, Iowa, United States | — |
+ 27 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05207670